SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: David Cathcart who wrote (6017)11/23/1998 2:29:00 PM
From: Vector1  Read Replies (2) | Respond to of 9719
 
David,
I am delighted that they have commenced phase II and pray they do some serious tumor shrinking. Pancreatic cacer is among the most agressive and anything that 114 can do would be an advance. I am disappointed that they have not announced a European partner and I thought the press release was somewhat hyped. If the stock continues into the double digits the valuation will not be totally covered by the value of Salagen sales. I am not a seller and am kicking myself for not buying more at $5 and $6..
V1